This study is the first to report on tirzepatide use in people with T1D using an AID system, Tandem Control-IQ
Common side effects of liraglutide are mainly gastrointestinal, and can include nausea, vomiting, constipation, or indigestion
Conversely, aged cardiovascular systems might respond differently to the peptides multiple mechanisms, and these differences remain unstudied
It was initially postulated that inhibition of DPP-IV would extend the half-life of endogenous GLP-1 and other incretins known to induce insulin secretion from the beta cell in a glucose-dependent manner
This is when you can expect gastrointestinal symptoms such as nausea, constipation, and vomiting
The full benefits of Tirzepatide may take a few months to become evident, as the medication works gradually to suppress hunger and improve insulin sensitivity